If youre taking a GLP-1 medication like Ozempic, Wegovy, or Mounjaro, youve likely heard how effective they can be for weight management and metabolic health (when prescribed and monitored by a qualified healthcare professional)
Indeed, for ILC2s we observed that this concentration did not precipitate changes in cellular viability ( Figures 3F, G ), and was additionally required to produce maximal suppression of ILC2 activity ( Figures 3H, I )
Tirzepatide (Mounjaro, Zepbound) Over 72 weeks , participants lost 15-21% of their body weight
Common side effects include hyperventilation, anorexia, abdominal pain, nausea, vomiting, lethargy, mental status changes, hypotension, acute kidney injury, and vaginal yeast infections
Int Clin Psychopharmacol 18:6171 Watson JC, Dyck PJ (2015) Peripheral neuropathy: a practical approach to diagnosis and symptom management